UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Abuse-Deterrent Formulation of OxyContin

The New England journal of medicine, 2012-07, Vol.367 (2), p.187-189

2012

Volltextzugriff (PDF)

Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder

PloS one, 2022-11, Vol.17 (11), p.e0271379

2022

Volltextzugriff (PDF)

Tissue-specific DNA methylation is conserved across human, mouse, and rat, and driven by primary sequence conservation

BMC genomics, 2017-09, Vol.18 (1), p.724-724, Article 724

2017

Volltextzugriff (PDF)

Abuse and diversion of buprenorphine sublingual tablets and film

Journal of substance abuse treatment, 2014-07, Vol.47 (1), p.27-34

2014

Volltextzugriff (PDF)

Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis

American journal of public health (1971), 2020-02, Vol.110 (2), p.244-250

2020

Volltextzugriff (PDF)

Twin epidemics: The surging rise of methamphetamine use in chronic opioid users

Drug and alcohol dependence, 2018-12, Vol.193, p.14-20

2018

Volltextzugriff (PDF)

Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin

JAMA psychiatry (Chicago, Ill.), 2015-05, Vol.72 (5), p.424

2015

Volltextzugriff (PDF)

Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers

Addictive behaviors, 2017-02, Vol.65, p.242-244

2017

Volltextzugriff (PDF)

Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States

PloS one, 2016-12, Vol.11 (12), p.e0167499

2016

Volltextzugriff (PDF)

Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations

Pain medicine (Malden, Mass.), 2007-03, Vol.8 (2), p.171-183

2007

Volltextzugriff (PDF)

Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States

The New England journal of medicine, 2015-10, Vol.373 (18), p.1789-1790

2015

Volltextzugriff (PDF)

The changing face of heroin use in the United States: a retrospective analysis of the past 50 years

JAMA psychiatry (Chicago, Ill.), 2014-07, Vol.71 (7), p.821

2014

Volltextzugriff (PDF)

Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts

Journal of opioid management, 2011-07, Vol.7 (4), p.258-264

2011

Volltextzugriff (PDF)

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose

Pharmaceuticals (Basel, Switzerland), 2021-12, Vol.14 (12), p.1279

2021

Volltextzugriff (PDF)

Co-morbidity and utilization of medical services by pain patients receiving opioid medications: Data from an insurance claims database

Pain (Amsterdam), 2009-07, Vol.144 (1-2), p.20-27

2009

Volltextzugriff (PDF)

Increased use of heroin as an initiating opioid of abuse

Addictive behaviors, 2017-11, Vol.74, p.63-66

2017

Volltextzugriff (PDF)

Is a Reduction in Access to Prescription Opioids the Cure for the Current Opioid Crisis?

American journal of public health (1971), 2018-10, Vol.108 (10), p.1322-1323

Cicero, Theodore J

2018

Volltextzugriff (PDF)

Trends in Opioid Analgesic Abuse and Mortality in the United States

The New England journal of medicine, 2015-01, Vol.372 (3), p.241-248

2015

Volltextzugriff (PDF)

The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse

Dialogues in clinical neuroscience, 2017-09, Vol.19 (3), p.259-269

2017

Volltextzugriff (PDF)

Understanding the use of diverted buprenorphine

Drug and alcohol dependence, 2018-12, Vol.193, p.117-123

2018

Volltextzugriff (PDF)

Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings

Preventive medicine, 2021-11, Vol.152, p.106729, Article 106729

2021

Volltextzugriff (PDF)

Increased use of heroin as an initiating opioid of abuse: Further considerations and policy implications

Addictive behaviors, 2018-12, Vol.87, p.267-271

2018

Volltextzugriff (PDF)

Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter?

Drug and alcohol dependence, 2017-04, Vol.173, p.S4-S10

2017

Volltextzugriff (PDF)

Abuse-deterrent Opioid Formulations

Anesthesiology (Philadelphia), 2018-05, Vol.128 (5), p.1015-1026

2018

Volltextzugriff (PDF)

Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids

Drug and alcohol dependence, 2017-08, Vol.177, p.101-103

2017

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(200)

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(137)
Male
(94)
Humans
(82)
Animals
(67)
Rats
(61)
Female
(51)
Biological And Medical Sciences
(50)
Pharmacology & Pharmacy
(45)
Opioid-Related Disorders - Epidemiology
(42)
Substance Abuse
(41)
Drug Abuse
(39)
Medical Sciences
(39)
Opioids
(31)
Adult
(29)
Narcotics
(28)
Psychiatry
(27)
United States - Epidemiology
(25)
Analgesics, Opioid - Adverse Effects
(23)
Dose-Response Relationship, Drug
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of Abuse-Deterrent Formulation of OxyContin

Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder

Tissue-specific DNA methylation is conserved across human, mouse, and rat, and driven by primary sequence conservation

Abuse and diversion of buprenorphine sublingual tablets and film

Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis

Twin epidemics: The surging rise of methamphetamine use in chronic opioid users

Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin

Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers

Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States

Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations

Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States

The changing face of heroin use in the United States: a retrospective analysis of the past 50 years

Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose

Co-morbidity and utilization of medical services by pain patients receiving opioid medications: Data from an insurance claims database

Increased use of heroin as an initiating opioid of abuse

Is a Reduction in Access to Prescription Opioids the Cure for the Current Opioid Crisis?

Trends in Opioid Analgesic Abuse and Mortality in the United States

The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse

Understanding the use of diverted buprenorphine

Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings

Increased use of heroin as an initiating opioid of abuse: Further considerations and policy implications

Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter?

Abuse-deterrent Opioid Formulations

Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids

Suchergebnisse filtern